Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data. | Genome Biol | 2021 | 34686194 | PubTator, text mining | PubMed |
| Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies. | Cells | 2021 | 34685678 | PubTator, text mining | PubMed |
| USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma. | Cells | 2021 | 34685632 | PubTator, text mining | PubMed |
| Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. | Pharmaceutics | 2021 | 34683974 | PubTator, text mining | PubMed |
| Possible Mechanisms of Subsequent Neoplasia Development in Childhood Cancer Survivors: A Review. | Cancers (Basel) | 2021 | 34680213 | PubTator, text mining | PubMed |
| Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens. | Sci Rep | 2021 | 34671057 | PubTator, text mining | PubMed |
| A novel upregulated LncRNA-AC026150.8 promotes chemo-resistance and predicts poor prognosis in acute myeloid leukemia. | Cancer Med | 2021 | 34664783 | PubTator, text mining | PubMed |
| TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis. | Nat Commun | 2021 | 34663818 | PubTator, text mining | PubMed |
| Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis. | Cell Death Discov | 2021 | 34663800 | PubTator, text mining | PubMed |
| Hyperthermia Selectively Destabilizes Oncogenic Fusion Proteins. | Blood Cancer Discov | 2021 | 34661159 | PubTator, text mining | PubMed |
| Deep semi-supervised learning ensemble framework for classifying co-mentions of human proteins and phenotypes. | BMC Bioinformatics | 2021 | 34656098 | PubTator, text mining | PubMed |
| RIPK3 signaling and its role in the pathogenesis of cancers. | Cell Mol Life Sci | 2021 | 34654937 | PubTator, text mining | PubMed |
| Advanced Flow Cytometry Analysis Algorithms for Optimizing the Detection of "Different From Normal" Immunophenotypes in Acute Myeloid Blasts. | Front Cell Dev Biol | 2021 | 34650981 | PubTator, text mining | PubMed |
| FusionAI: Predicting fusion breakpoint from DNA sequence with deep learning. | iScience | 2021 | 34646994 | PubTator, text mining | PubMed |
| Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT. | Front Oncol | 2021 | 34646774 | PubTator, text mining | PubMed |
| Mutation signatures of pediatric acute myeloid leukemia and normal blood progenitors associated with differential patient outcomes. | Blood Cancer Discov | 2021 | 34642666 | PubTator, text mining | PubMed |
| ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape. | Int J Mol Sci | 2021 | 34639154 | PubTator, text mining | PubMed |
| Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients. | Int J Mol Sci | 2021 | 34638823 | PubTator, text mining | PubMed |
| Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34638301 | PubTator, text mining | PubMed |
| Epitranscriptomic modifications in acute myeloid leukemia: m6A and 2'-O-methylation as targets for novel therapeutic strategies. | Biol Chem | 2021 | 34634841 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=51